Intraindividual consistency of the activated protein C resistance phenotype

British Journal of Haematology

Volumn 126, Issue 3, 2004, Pages 405-409

  Tosetto, Alberto ^a   Simioni, Monica ^a   Madeo, Domenico ^a   Rodeghiero, Francesco ^a  

^a SAN BORTOLO HOSPITAL   (Italy)

Author keywords

Activated protein C resistance; Epidemiology; Factor V Leiden; Genetic; Thrombophilia

Indexed keywords

BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 8; PROTHROMBIN;

ACTIVATED PROTEIN C RESISTANCE; ADULT; ALLELE; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; FEMALE; HEREDITY; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PLASMA FACTOR; PRIORITY JOURNAL; RISK FACTOR; THROMBOPHILIA;

ACTIVATED PROTEIN C RESISTANCE; ADOLESCENT; ADULT; ALLELES; ANALYSIS OF VARIANCE; BLOOD COAGULATION TESTS; CROSS-SECTIONAL STUDIES; FACTOR V; FACTOR VIII; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; PHENOTYPE; PROTEIN C; PROTHROMBIN; THROMBOPHILIA; TIME FACTORS;

EID: 3442880521     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2004.05059.x     Document Type: Article

References (25)

1. Brown, K., Luddington, R., Williamson, D., Baker, P. & Baglin, T. (1997) Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3′-untranslated region of the prothrombin gene. British Journal of Haematology, 98, 907-909.
2. Castaman, G., Tosetto, A., Cappellari, A., Ruggeri, M. & Rodeghiero, F. (2000) The A20210 allele in the prothrombin gene enhances the risk of venous thrombosis in carriers of inherited protein S deficiency. Blood Coagulation Fibrinolysis, 11, 321-326.
3. Castaman, G., Tosetto, A., Simioni, M., Ruggeri, M., Madeo, D. & Rodeghiero, F. (2001) Phenotypic APC resistance in carriers of the A20210 prothrombin mutation is associated with an increased risk of venous thrombosis. Thrombosis and Haemostasis, 86, 804-808.
4. Chan, W.P., Lee, C.K., Kwong, Y.L., Lam, C.K. & Liang, R. (1998) A novel mutation of Arg306 of factor V gene in Hong Kong Chinese. Blood, 91, 1135-1139.
5. De Visser, M.C.H., Rosendaal, F.R. & Bertina, R.M. (1999) A Reduced Sensitivity for Activated Protein C in the Absence of Factor V Leiden Increases the Risk of Venous Thrombosis. Blood, 93, 1271-1276.
6. De Visser, M.C.H., Sandkuijl, L.A., Lensen, R.P., Vos, H.L., Rosendaal, F.R. & Bertina, R.M. (2003) Linkage analysis of factor VIII and von Willebrand factor loci as quantitative trait loci. Journal of Thrombosis and Haemostasis, 8, 1771-1776.
7. Henkens, C.M., van der Meer, J., van der Schaaf, W., Pelsma, P.M., Geerards, S., Seinen, A. & Bom, V.J. (1995) Sensitivity to activated protein C (APC) related with sex, use of oral contraceptives and FVIII. Thrombosis and Haemostasis, 73, 1120 (abstract).
8. Kamphuisen, P.W., Houwing Duistermaat, J.J., van Houwelingen, H.C., Eikenboom, J.C., Bertina, R.M. & Rosendaal, F.R. (1998) Familial clustering of factor VIII and von Willebrand factor levels. Thrombosis and Haemostasis, 79, 323-327.
9. Kamphuisen, P.W., Eikenboom, J.C., Rosendaal, F.R., Koster, T., Blann, A.D., Vos, H.L. & Bertina, R.M. (2001) High factor VIII antigen levels increase the risk of venous thrombosis but are not associated with polymorphisms in the von Willebrand factor and factor VIII gene. British Journal of Haematology, 115, 156-158.
10. Kleinbaum, D.G., Kupper, L.L. & Muller, K.E. (1988) Applied Regression Analysis and Other Multivariable Methods. PWS-Kent Publishing Co., Boston.
11. Koster, T., Blann, A.D., Briet, E., Vandenbroucke, J.P. & Rosendaal, F.R. (1995) Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep vein thrombosis. Lancet, 345, 152-155.
12. Mansvelt, E.P.G., Laffan, M., McVey, J.H. & Tuddenham, E.G. (1998) Analysis of the F8 gene in individuals with high plasma factor VIII-.C levels and associated venous thrombosis. Thrombosis and Haemostasis, 80, 561-565.
13. Mingozzi, F., Legnani, C., Lunghi, B., Scanavini, D., Castoldi, E., Palareti, G., Marchetti, G. & Bernardi, F. (2003) A FV multiallelic marker detects genetic components of APC resistance contributing to venous thromboembolism in FV Leiden carriers. Thrombosis and Haemostasis, 89, 983-989.
14. Poort, S.R., Rosendaal, F.R., Reitsma, P.H. & Bertina, R. (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood, 88, 3698-3703.
15. Rodeghiero, F. & Tosetto, A. (1996) The VITA Project: Population-based distribution of protein C, antithrombin III, heparin cofactor II and plasminogen. Relationship with physiological variables and establishment of reference ranges. Thrombosis and Haemostasis, 76, 226-233.
16. Rodeghiero, F. & Tosetto, A. (1997) The epidemiology of inherited thrombophilia: the VITA Project. Thrombosis and Haemostasis, 78, 636-640.
17. Rodeghiero, F. & Tosetto, A. (1999) Activated Protein C Resistance and Factor V gene mutation are independent risk factors for venous thromboembolism. Annals of Internal Medicine, 130, 643-650.
18. Schambeck, C.M., Hinney, K., Haubitz, I., Mansouri, T.B., Wahler, D. & Keller, F. (2001) Familial clustering of high factor VIII levels in patients with venous thromboembolism. Arteriosclerosis, Thrombosis and Vascular Biology, 21, 289-292.
19. Soria, J.M., Almasy, L., Souto, J.C., Buil, A., Martinez-Sanchez, E., Mateo, J., Borrell, M., Stone, W.H., Lathrop, M., Fontcuberta, J. & Blangero, J. (2003) A new locus on chromosome 18 that influences normal variation in activated protein C resistance phenotype and factor VIII activity and its relation to thrombosis susceptibility. Blood, 101, 163-167.
20. Souto, J.C., Almasy, L., Borrell, M., Gari, M., Martinez, E., Mateo, J., Stone, W.H., Blangero, J. & Fontcuberta, J. (2000) Genetic determinants of hemostasis phenotypes in Spanish families. Circulation, 101, 1546-1551.
21. Tosetto, A., Missiaglia, E., Gatto, E. & Rodeghiero, F. (1997) The Vita Project: phenotypic resistance to activated protein C and FV Leiden mutation in the general population. Thrombosis and Haemostasis, 78, 859-863.
22. Tosetto, A., Missiaglia, E., Frezzato, M. & Rodeghiero, F. (1999) The VITA Project: prothrombin G20210A mutation and venous thromboembolism in the general population. Thrombosis and Haemostasis, 82, 1395-1398.
23. Tosetto, A., Castaman, G-, Cappellari, A. & Rodeghiero, F. (2000) The VITA Project: heritability of resistance to activated protein C. Vincenza Thrombophilia and Arteriosclerosis. Thrombosis and Haemostasis, 84, 811-814.
24. Tripodi, A., Negri, B., Bertina, R.M. & Mannucci, P.M. (1997) Screening for the FV:Q506 mutation - Evaluation of thirteen plasma-based methods for their diagnostic efficacy in comparison with DNA analysis. Thrombosis and Haemostasis, 77, 436-439.
25. Tripodi, A., Chantarangkul, V. & Mannucci, P.M. (2000) Hyperprothrombinemia may result in acquired activated protein C resistance. Blood, 96, 3295-3296.